A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers.
Saved in:
| Title: | A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers. |
|---|---|
| Authors: | Jeong, Angela1 (AUTHOR), Weisel, Kathleen2 (AUTHOR), Dimitrova, Dessislava2 (AUTHOR), Donnelly, Brianna3 (AUTHOR), Wang, Daniel4 (AUTHOR), Vermeulen, An5 (AUTHOR), Xu, Zhenhua1 (AUTHOR) zxu5@its.jnj.com |
| Source: | Clinical Pharmacology in Drug Development. Jan2026, Vol. 15 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
